Research priorities for accelerating the achievement of three 95 HIV goals in Cameroon: a consensus statement from the Cameroon HIV Research Forum (CAM-HERO)

• Published in: The Pan African medical journal Vol. 40; p. 124
• Main Authors: Dzudie, Anastase, Tchounga, Boris, Ajeh, Rogers, Kouanfack, Charles, Ebasone, Peter Vanes, Djikeussi, Tatiana, Nyoto, Léonard Bonono, Fokam, Joseph, Ateudjieu, Jérôme, Tchendjou, Patrice, Semengue, Ezechiel Ngoufack Jagni, Kamgang, Fabrice Youbi, Anoubessi, Jean, Varloteaux, Marie, Youngui, Boris, Tabala, Felicite Naah, Atanga, Benjamin, Simo, Leonie, Zemsi, Armel, Shu, Emile Nforbih, Ndayisaba, Gilles, Nyenti, Annereke, Ntabe, Apungwa Cornelius, Bwemba, Therese Abong, Sobngwi, Eugene, Billong, Serge Clotaire, Ditekemena, John, Bissek, Anne Cecile Zoung-Kanyi, Njock, Louis Richard
• Format: Journal Article
• Language: English
• Published: Uganda The African Field Epidemiology Network 2021
• Subjects: Adolescent; Cameroon; Child; Consensus; Goals; HIV Infections - drug therapy; HIV Infections - epidemiology; Humans; Cameroon; HIV/AIDS; Cameroon; research priorities; Treat all
• ISSN: 1937-8688; 1937-8688
• DOI: 10.11604/pamj.2021.40.124.31068

the Treat-All remains the globally endorsed approach to attain the 95-95-95 targets and end the AIDS pandemic by 2030, but requires some country-level contextualization. In Cameroon, the specific research agenda to inform strategies for improving HIV policy was yet to be defined. under the patronage of the Cameroon Ministry of health, researchers, policy makers, implementing partners, and clinicians from 13 institutions, used the Delphi method to arrive at a consensus of HIV research priorities. The process had five steps: 1) independent literature scan by 5 working groups; 2) review of the initial priority list; 3) appraisal of priorities list in a larger group; 4) refinement and consolidation by a consensus group; 5) rating of top research priorities. five research priorities and corresponding research approaches, resulted from the process. These include: 1) effectiveness, safety and active toxicity monitoring of new and old antiretrovirals; 2) outcomes of Antiretroviral Therapy (ART) with focus in children and adolescents; 3) impact of HIV and ART on aging and major chronic diseases; 4) ART dispensation models and impact on adherence and retention; 5) evaluations of HIV treatment and prevention programs. the research priorities resulted from a consensus amongst a multidisciplinary team and were based on current data about the pandemic and science to prevent, treat, and ultimately cure HIV. These priorities highlighted critical areas of investigation with potential relevance for the country, funders, and regulatory bodies.